CD37-binding molecules and immunoconjugates thereof
US-9447189-B2 · Sep 20, 2016 · US
This page is not indexed by search engines while we improve data quality.
Park Peter U patents
Park Peter U holds 6 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 6 |
| Recent patents | 0 |
| First publication | Nov 3, 2015 |
| Latest publication | Sep 20, 2016 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
US-9314522-B2 · Apr 19, 2016 · US
Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
US-9238690-B2 · Jan 19, 2016 · US
Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate
US-9233171-B2 · Jan 12, 2016 · US
CD20 antibodies and uses thereof
US-9173961-B2 · Nov 3, 2015 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
CD37-binding molecules and immunoconjugates thereof
US-9447189-B2 · Sep 20, 2016 · US
Antitumors combinations containing antibodies recognizing specifically CD38 and bortezomib
US-9314522-B2 · Apr 19, 2016 · US
Non-antagonistic EGFR-binding molecules and immunoconjugates thereof
US-9238690-B2 · Jan 19, 2016 · US
Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate
US-9233171-B2 · Jan 12, 2016 · US
CD20 antibodies and uses thereof
US-9173961-B2 · Nov 3, 2015 · US
Top CPC classifications
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| C07K2317/24 | 6 |
| A61P35/00 | 6 |
| C07K2317/73 | 5 |
| C07K2317/565 | 5 |
| A61K2039/505 | 5 |
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 6 |
| Chemistry & Metallurgy | 6 |
| Physics | 3 |